Close Menu
  • Coins
    • Bitcoin
    • Ethereum
    • Altcoins
    • NFT
  • Blockchain
  • DeFi
  • Metaverse
  • Regulation
  • Other
    • Exchanges
    • ICO
    • GameFi
    • Mining
    • Legal
  • MarketCap
Facebook X (Twitter) Instagram
  • Back to NBTC homepage
  • Privacy Policy
  • Contact
X (Twitter) Telegram Facebook LinkedIn RSS
NBTC News
  • Coins
    • Bitcoin
    • Ethereum
    • Altcoins
    • NFT
  • Blockchain
  • DeFi
  • Metaverse
  • Regulation
  • Other
    • Exchanges
    • ICO
    • GameFi
    • Mining
    • Legal
  • MarketCap
NBTC News
DeFi

Enzyme Partners with Compound DAO to Optimize Treasury Management through On-Chain Options

NBTCBy NBTC14/07/2025No Comments2 Mins Read

[ad_1]

Enzyme Finance, an Ethereum-based decentralized platform for asset management on-chain, has announced its new partnership with Compound DAO, an Ethereum-based DeFi protocol that permits crypto borrowing and lending. The partnership aims to optimize the management of treasury via unique on-chain options. The platform shared the details of this initiative in a recent X post.

Onchain options are becoming a way to make treasuries work harder. Here’s an example 👇@compoundfinance DAO recently demonstrated a sophisticated approach by integrating covered calls into their treasury strategy using Enzyme.Myso, targeting a ~15% APY.

The objective is… pic.twitter.com/ZhDJDQoQ1t

— Enzyme (@enzymefinance) July 13, 2025

Enzyme Finance and Compound Collaborate for Optimized Treasury Management

The collaboration between Enzyme Finance and Compound DAO focuses on treasury management with robust optimization. This development underscores a noteworthy step in the evolution of decentralized autonomous organizations (DAOs) to enhance capital management. In this respect, the partnership integrates covered calls, which is an options strategy to generate yield while also retaining asset exposure. With this, Compound DAO targets a 15% annual percentage yield (APY).

Keeping this in view, the development is devoted to enhancing the idle assets’ productivity while maintaining a controlled and clear risk profile. At the core of this collaboration is Enzyme.Myso, which is a DeFi-native platform to enable execution and creation of diverse strategies concerning on-chain options. With local support for completely auditable flows as well as a framework for institutional-level DAOs and apps, Enzyme.Myso delivers the security and transparency that treasury operations require.

Driving Shift in DeFi Sector with Responsible Deployment of Idle Funds to Offer Sustainable Growth

According to Enzyme Finance, Compound DAO’s integration of covered calls highlights a wider trend toward data-led and professionalized treasury management among decentralized organizations. Conventionally, DAOs have frequently faced capital inefficiency, often holding huge balances in governance tokens or stablecoins without any yield generation.

However, now, this partnership denotes a strategic shift in the case of responsible deployment of such funds for sustainable expansion. Overall, the joint effort plays the role of a blueprint for the rest of the institutional players and DAOs attempting to leverage DeFi options sector.


[ad_2]

NBTC

Related Posts

Hong Kong working to allow perpetual contracts, chief regulator says

11/02/2026

Spark looks to build building a safe bridge between onchain capital and TradFi

11/02/2026

DeFi is not really decentralized, it is unavoidably centralized

11/02/2026

STON.fi Opens TON DeFi to Bitcoin and Ethereum

11/02/2026
Add A Comment

Comments are closed.

Type above and press Enter to search. Press Esc to cancel.